AstraZeneca asks Supreme Court to hear lawsuit challenging Medicare drug price negotiation
NeutralU.S News

AstraZeneca is taking a significant step by asking the Supreme Court to review its lawsuit against the Medicare Drug Price Negotiation Program established by the Inflation Reduction Act. This case, filed on September 19, raises important questions about the implications of the IRA for pharmaceutical manufacturers. The outcome could have far-reaching effects on how drug prices are negotiated and the overall landscape of the pharmaceutical industry, making it a crucial issue for both companies and consumers.
— Curated by the World Pulse Now AI Editorial System